Gut microbiome and avascular necrosis: A scoping review of current evidence and knowledge gaps

Bone · Published 2026-08-01 · DOI 10.1016/j.bone.2026.118041

Authors (5)

Tomasz Poboży, Kamil Poboży, Julia Domańska-Poboża, Andrzej Kotela, Wojciech Konarski

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Poboży, T., Poboży, K., Domańska-Poboża, J., et al. (2026). Gut microbiome and avascular necrosis: A scoping review of current evidence and knowledge gaps. Bone. https://doi.org/10.1016/j.bone.2026.118041

Related articles

• Causal association between gut microbiota and osteonecrosis in European populations: a two-sample Mendelian randomization analysis · Journal of Bone and Mineral Metabolism · 2026 · Cites or is cited by this article
• Pathophysiology and risk factors for osteonecrosis · Current Reviews in Musculoskeletal Medicine · 2015 · Cites or is cited by this article
• Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017–2023 · Bone · 2026 · Same journal
• Unsupervised machine learning derived bone phenotypes exhibit differential biomarker responses following acute ballistic loaded exercise · Bone · 2026 · Same journal
• Perspective on unmet need for effective treatment in fibrous dysplasia and rare paediatric bone disease · Bone · 2026 · Same journal
• Roles of circulating proteins in osteoporosis pathogenesis: Insights from Mendelian randomization · Bone · 2026 · Same journal
• Body composition and energy expenditure of patients with Fibrodysplasia Ossificans Progressiva · Bone · 2026 · Same journal
• The fracture healing diet. Can nutritional supplements enhance osteogenic potential and fracture healing? A scoping review of current literature · Bone · 2026 · Same journal
• Complexity of genomic diagnosis: Lessons learnt from the UK Biobank and Generation study newborn genome sequencing analyses · Bone · 2026 · Same journal
• Partial lumbar spine response in hip non-responders to romosozumab: Baseline bone mineral density as the principal determinant in a multi-center real-world Japanese cohort (n = 398) · Bone · 2026 · Same journal